Assael BM[au] - Search Results

Year	Number of Results
1975	3
1976	1
1977	2
1978	1
1979	1
1980	3
1981	3
1982	9
1983	7
1984	3
1985	4
1986	6
1987	2
1988	3
1990	2
1991	2
1993	1
1994	3
1995	2
1996	2
1997	1
1998	3
1999	7
2000	2
2001	3
2002	4
2003	2
2004	1
2005	4
2006	7
2007	6
2008	3
2009	4
2010	2
2011	6
2012	5
2013	6
2014	8
2015	6
2016	10
2017	5
2018	7
2019	3
2020	2
2022	0

1

Cystic fibrosis: a clinical view.

Castellani C, Assael BM. Castellani C, et al. Among authors: assael bm. Cell Mol Life Sci. 2017 Jan;74(1):129-140. doi: 10.1007/s00018-016-2393-9. Epub 2016 Oct 5. Cell Mol Life Sci. 2017. PMID: 27709245 Review.

2

Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice.

Castellani C, Cuppens H, Macek M Jr, Cassiman JJ, Kerem E, Durie P, Tullis E, Assael BM, Bombieri C, Brown A, Casals T, Claustres M, Cutting GR, Dequeker E, Dodge J, Doull I, Farrell P, Ferec C, Girodon E, Johannesson M, Kerem B, Knowles M, Munck A, Pignatti PF, Radojkovic D, Rizzotti P, Schwarz M, Stuhrmann M, Tzetis M, Zielenski J, Elborn JS. Castellani C, et al. Among authors: assael bm. J Cyst Fibros. 2008 May;7(3):179-96. doi: 10.1016/j.jcf.2008.03.009. J Cyst Fibros. 2008. PMID: 18456578 Free PMC article. Review.

3

When and how ruling out cystic fibrosis in adult patients with bronchiectasis.

Gramegna A, Aliberti S, Seia M, Porcaro L, Bianchi V, Castellani C, Melotti P, Sorio C, Consalvo E, Franceschi E, Amati F, Contarini M, Gaffuri M, Roncoroni L, Vigone B, Bellofiore A, Del Monaco C, Oriano M, Terranova L, Patria MF, Marchisio P, Assael BM, Blasi F. Gramegna A, et al. Among authors: assael bm. Multidiscip Respir Med. 2018 Aug 9;13(Suppl 1):29. doi: 10.1186/s40248-018-0142-7. eCollection 2018. Multidiscip Respir Med. 2018. PMID: 30151190 Free PMC article. Review.

4

Aztreonam inhalation solution for suppressive treatment of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis.

Assael BM. Assael BM. Expert Rev Anti Infect Ther. 2011 Nov;9(11):967-73. doi: 10.1586/eri.11.131. Expert Rev Anti Infect Ther. 2011. PMID: 22029514 Review.

5

Ototoxicity of aminoglycoside antibiotics in infants and children.

Assael BM, Parini R, Rusconi F. Assael BM, et al. Pediatr Infect Dis. 1982 Sep-Oct;1(5):357-65. doi: 10.1097/00006454-198209000-00017. Pediatr Infect Dis. 1982. PMID: 6760147 Review. No abstract available.

6

Bacterial infections and inflammation in the lungs of cystic fibrosis patients.

Conese M, Assael BM. Conese M, et al. Among authors: assael bm. Pediatr Infect Dis J. 2001 Feb;20(2):207-13. doi: 10.1097/00006454-200102000-00018. Pediatr Infect Dis J. 2001. PMID: 11224844 Review.

7

Pharmacokinetics and drug distribution during postnatal development.

Assael BM. Assael BM. Pharmacol Ther. 1982;18(2):159-97. doi: 10.1016/0163-7258(82)90066-3. Pharmacol Ther. 1982. PMID: 6760214 Review. No abstract available.

8

Ampicillin kinetics in pregnancy.

Assael BM, Como ML, Miraglia M, Pardi G, Sereni F. Assael BM, et al. Br J Clin Pharmacol. 1979 Sep;8(3):286-8. doi: 10.1111/j.1365-2125.1979.tb01018.x. Br J Clin Pharmacol. 1979. PMID: 497097 Free PMC article. No abstract available.

9

Early antibiotic treatment of pseudomonas aeruginosa colonisation in cystic fibrosis: a critical review of the literature.

Marchetti F, Giglio L, Candusso M, Faraguna D, Assael BM. Marchetti F, et al. Among authors: assael bm. Eur J Clin Pharmacol. 2004 Apr;60(2):67-74. doi: 10.1007/s00228-004-0735-2. Epub 2004 Mar 5. Eur J Clin Pharmacol. 2004. PMID: 15004732 Review.

10

Prostaglandins and aminoglycoside nephrotoxicity.

Assael BM, Chiabrando C, Gagliardi L, Noseda A, Bamonte F, Salmona M. Assael BM, et al. Toxicol Appl Pharmacol. 1985 May;78(3):386-94. doi: 10.1016/0041-008x(85)90244-3. Toxicol Appl Pharmacol. 1985. PMID: 4049389

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results